EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Combined benznidazole and pentoxifylline therapy improves behavioral and cognitive changes in association with the regulation of systemic inflammatory profile in chronic experimental Chagas disease

Glaucia Vilar-Pereira, Leda Margarita Castaño-Barrios, Isabela Resende Pereira, Ana Paula da Silva Pinheiro, Thayse do Espírito Santo Protásio da Silva, Lina L Hernandez-Velasco iD, Priscila Silva Grijó Farani, Aditi Kulkarni, Sourav Roy, Hílton Antônio Mata Dos Santos, Raquel de Oliveira Lopes, Luzineide Wanderley Tinoco iD und 4 weitere

PLOS One · 2025

DOI: 10.1371/journal.pone.0334708 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Glaucia Vilar-Pereira und 15 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Biologia das Interações, Instituto Oswaldo Cruz/Fiocruz, Rio de Janeiro, Rio de Janeiro, Brazil. Hauptthemen laut MEDLINE: Pentoxifylline, Chagas Disease, Nitroimidazoles, Behavior, Animal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronically Trypanosoma cruzi -infected mice show signs of behavioral and cognitive changes, resembling aspects of Chagas disease patients. Inflammatory mediators, such as cytokines and nitric oxide (NO) have been linked to mental disorders. Preclinical studies showed the partial effects of the trypanossomicidal drug benznidazole (Bz) on mnemonic alterations. Here, we investigated the participation of the parasite and systemic inflammatory profile in behavioral and cognitive changes, using Bz combined with the immunoregulator pentoxifylline (PTX). Chronically T. cruzi -infected C57BL/6 mice were treated with Bz (25 mg/Kg/day) and PTX (20 mg/Kg/day) as mono or combined therapies, submitted to behavioral tests, and canonical biological stressors were analyzed. Bz therapy had no effects on anxiety, but partially ameliorated innate compulsive behavior, depression, and memory loss, while PTX and, mainly, Bz + PTX had a broader beneficial effect on these changes. Bz and Bz + PTX reduced parasitemia. The three therapies decreased the parasite burden in the brain. Bz and Bz + PTX therapies reduced oxidative stress in the brain tissue, while PTX and Bz + PTX therapies efficiently controlled the elevated concentrations of GABA/glutamate in the cerebral cortex. Even after parasite control, serum concentrations of NO and tumor necrosis factor (TNF) enhanced as the disease progressed. Bz and, mainly, Bz + PTX treatments reduced NO levels. The three therapeutic schemes hamper the progressive increase of TNF levels. Reanalysis of available data on the systemic miRNA transcriptome supports the beneficial role of Bz + PTX therapy on pivotal hubs involved in inflammation of the central nervous system and neurodegenerative disorders. Moreover, principal components analysis (PCA-2D and 3D projections) underlined the distinction between the noninfected and vehicle-treated infected groups, while Bz + PTX-treated infected mice were closer to noninfected controls. The combined Bz + PTX therapy reduced parasite load and regulated pivotal neurochemical changes in the brain and the systemic inflammatory profile, improving behavioral and cognitive changes in a model of Chagas disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PentoxifyllineChagas DiseaseNitroimidazolesBehavior, AnimalTrypanocidal AgentsCognitionAnimalsMiceMice, Inbred C57BLTrypanosoma cruziDrug Therapy, CombinationInflammationMaleBrainDisease Models, AnimalChronic DiseaseOxidative Stress

Substanzen

PentoxifyllinebenzonidazoleNitroimidazolesTrypanocidal Agents

Autor:innen und Institutionen

  • Laboratório de Biologia das Interações, Instituto Oswaldo Cruz/Fiocruz, Rio de Janeiro, Rio de Janeiro, Brazil.
  • Departamento de Microbiologia e Parasitologia, Instituto de Biologia, Universidade Federal de Pelotas, Pelotas, Rio Grande do Sul, Brazil.
  • Departamento de Matematicas, Pontificia Universidad Javeriana, Bogotá, Colombia.
  • Laboratório de Virologia e Parasitologia Molecular, IOC/Fiocruz, Rio de Janeiro, Rio de Janeiro, Brazil.
  • Department of Biological Sciences and Border Biomedical Research Center, University of Texas at El Paso, El Paso, Texas, United States of America.
  • Escola de Farmácia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil.

ORCID-Profile: Lina L Hernandez-Velasco, Luzineide Wanderley Tinoco, Andrea Alice Silva, Joseli Lannes-Vieira

Förderung

  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
  • Fundação Oswaldo Cruz

Zitieren

APA

Vilar-Pereira, G., Castaño-Barrios, L. M., Pereira, I. R., da Silva Pinheiro, A. P., do Espírito Santo Protásio da Silva, T., Hernandez-Velasco, L. L., Silva Grijó Farani, P., Kulkarni, A., Roy, S., Mata Dos Santos, H. A., de Oliveira Lopes, R., Tinoco, L. W., Britto, C., Moreira, O. C., Silva, A. A., & Lannes-Vieira, J. (2025). Combined benznidazole and pentoxifylline therapy improves behavioral and cognitive changes in association with the regulation of systemic inflammatory profile in chronic experimental Chagas disease. PLOS One. https://doi.org/10.1371/journal.pone.0334708

Vancouver

Vilar-Pereira G, Castaño-Barrios LM, Pereira IR, da Silva Pinheiro AP, do Espírito Santo Protásio da Silva T, Hernandez-Velasco LL, et al. Combined benznidazole and pentoxifylline therapy improves behavioral and cognitive changes in association with the regulation of systemic inflammatory profile in chronic experimental Chagas disease. PLOS One. 2025. doi:10.1371/journal.pone.0334708

BibTeX
@article{VilarPereira2025,
  author = {Vilar-Pereira, Glaucia and Castaño-Barrios, Leda Margarita and Pereira, Isabela Resende and da Silva Pinheiro, Ana Paula and do Espírito Santo Protásio da Silva, Thayse and Hernandez-Velasco, Lina L and Silva Grijó Farani, Priscila and Kulkarni, Aditi and Roy, Sourav and Mata Dos Santos, Hílton Antônio and de Oliveira Lopes, Raquel and Tinoco, Luzineide Wanderley and Britto, Constança and Moreira, Otacílio Cruz and Silva, Andrea Alice and Lannes-Vieira, Joseli},
  title = {Combined benznidazole and pentoxifylline therapy improves behavioral and cognitive changes in association with the regulation of systemic inflammatory profile in chronic experimental Chagas disease},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0334708}
}
Kostenlos starten →